Publications
- Parkinson JF, Sekhon LHS
Surgical Management of Spinal Epidural Abscess: Selection of Approach Based on MRI Appearance
Journal of Clinical Neuroscience 11:130-133, 2004 Feb - Parkinson JF, Sekhon LHS
Cervical Arthroplasty Complicated By Delayed Spontaneous Fusion Case Report
Journal of Neurosurgery (Spine) 2(3):377-80, 2005 Mar - Parkinson JF, Sekhon LHS
Cervical arthroplasty for the treatment of cervical spine disease
Australasian Musculoskeletal Medicine 9:28-31, 2004 - Parkinson JF, Sekhon LHS
Surgical Management of Spinal Epidural Abscess: Selection of Approach Based on MRI Appearance
Journal of Clinical Neuroscience 11:130-133, 2004 Feb - Parkinson JF, Sekhon LHS
Cervical Arthroplasty Complicated By Delayed Spontaneous Fusion Case Report
Journal of Neurosurgery (Spine) 2(3):377-80, 2005 Mar - Parkinson JF, Sekhon LHS
Cervical arthroplasty for the treatment of cervical spine disease
Australasian Musculoskeletal Medicine 9:28-31, 2004 - Parkinson JF, Sekhon LHS
Spinal epidural abscess: appearance on magnetic resonance imaging as a guide to surgical management
Neurosurgical Focus 17:E12, 2004 - McDonald K, Parkinson J, Wheeler H et al.
Identification of gene /protein sets that discriminate high grade gliomas from low grade
Neuro-Oncology 8(4):423-423, 2006 Oct (Abstract) - McDonald KL, Parkinson JF, Wheeler HR et al
Methylation of MGMT promoter in glioblastoma – Correlation between methylation-specific PCR, sequencing, and mRNA expression
Neuro-Oncology 8(4):461-461, 2006 Oct (Abstract) - Parkinson JF, McDonald KL, Wheeler H, et al
Variation in methylation status of MGMT promoter in serial glioblastoma specimens
Neuro-Oncology 8(4):461-462, 2006 Oct (Abstract) - McDonald KL, O’Sullivan MG, Parkinson JF et al
IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients
Journal of Neuropathology and Experimental Neurology 66(5):405-17, 2007 May - McDonald K, O’Sullivan M, Parkinson J, et al.
IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients
Neuro-Oncology 9(4):541-541, 2007 Oct (Abstract) - Parkinson JF, Wheeler HR, McDonald KL
Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma
Journal of Clinical Neuroscience 15(1):1-8, 2008 Jan - Parkinson JF, Wheeler HR, Clarkson A et al.
Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
Journal of Neuro-oncology 87(1):71-8, 2008 Mar - Payne CA, Maleki S, Messina M, O’Sullivan MG, Stone G, Hall NR, Parkinson JF et al.
Loss of Prostaglandin D2 Synthase: A key molecular event in the transition of a low grade astrocytoma to an anaplastic astrocytoma
Molecular Cancer Therapeutics 7(10):3420-8, 2008 Oct - Tacon LJ, Parkinson JF, Hudson BJ et al.
Headache of a diagnosis: frontotemporal pain and inflammation associated with osteolysis.
Medical Journal of Australia 189(10):591-2, 2008 Nov 17 - Li D, Brennan JW, Buckland, ME, Parkinson JF
Bronchogenic Carcinoid Metastasis to the Intramedullary Spinal Cord
Journal of Clinical Neuroscience, 17(9):1196-98, 2010 Sept - Parkinson JF, Afaghi V, Payne CA et al.
The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years experience at a single centre
Journal of Clinical Neuroscience, 18(3):329-33, 2011 March - Tan KL, Parkinson JF, McGee-Collett MG, Buckland ME
Spinal intradural malignant peripheral nerve sheath tumour
Pathology, 43(3):278-80, 2011 April - Sevim H, Parkinson JF, McDonald KL
Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?
Journal of Cancer Research and Clinical Oncology 137(11):1705-12, 2011 November - Parker NR, Khong P, Parkinson JF, Howell VM, Wheeler HR.
Molecular heterogeneity in glioblastoma: potential clinical implications.
Frontiers in Oncology 5:55, 2015 Mar 3 - Chan DL, Schembri G, Back M, Bailey DL, Roach PJ, Wheeler H, Cook R, Parkinson J, Lee A, Jayamanne D, Drummond J, Hsiao E.
FET PET in the evaluation of indeterminate brain lesions on MRI: differentiating glioma from other non-neoplastic causes.
European Journal of Nuclear Medicine and Molecular Imaging 42:S603, 2015 Oct (Abstract) - Parker NR, Hudson AL, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Cheng ZJ, Vafaee F, Chen J, Wheeler HR, Howell VM.
Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.
Scientific Reports 6:22477, 2016 Mar 4 - French H, Somasundaram A, Biggs M, Parkinson J, Allan R, Ball J, Little N.
Idiopathic intradural dorsal thoracic arachnoid cysts: A case series and review of the literature.
Journal of Clinical Neuroscience 40:147-152, 2017 Jun - Harris G, Jayamanne D, Wheeler H, Gzell C, Kastelan M, Schembri G, Brazier D, Cook R, Parkinson J, Khasraw M, Louw S, Back M.
Survival outcome of elderly patients with Glioblastoma Multiforme in their seventy fifth year or older treated with adjuvant therapy.
International Journal of Radiation Oncology*Biology*Physics In press, Published online 2017 Feb 20 - Parkinson JF, Sekhon LHS
Spinal epidural abscess: appearance on magnetic resonance imaging as a guide to surgical management
Neurosurgical Focus 17:E12, 2004 - McDonald K, Parkinson J, Wheeler H et al.
Identification of gene /protein sets that discriminate high grade gliomas from low grade
Neuro-Oncology 8(4):423-423, 2006 Oct (Abstract) - McDonald KL, Parkinson JF, Wheeler HR et al
Methylation of MGMT promoter in glioblastoma – Correlation between methylation-specific PCR, sequencing, and mRNA expression
Neuro-Oncology 8(4):461-461, 2006 Oct (Abstract) - Parkinson JF, McDonald KL, Wheeler H, et al
Variation in methylation status of MGMT promoter in serial glioblastoma specimens
Neuro-Oncology 8(4):461-462, 2006 Oct (Abstract) - McDonald KL, O’Sullivan MG, Parkinson JF et al
IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients
Journal of Neuropathology and Experimental Neurology 66(5):405-17, 2007 May - McDonald K, O’Sullivan M, Parkinson J, et al.
IQGAP1 and IGFBP2: Valuable biomarkers for determining prognosis in glioma patients
Neuro-Oncology 9(4):541-541, 2007 Oct (Abstract) - Parkinson JF, Wheeler HR, McDonald KL
Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma
Journal of Clinical Neuroscience 15(1):1-8, 2008 Jan - Parkinson JF, Wheeler HR, Clarkson A et al.
Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
Journal of Neuro-oncology 87(1):71-8, 2008 Mar - Payne CA, Maleki S, Messina M, O’Sullivan MG, Stone G, Hall NR, Parkinson JF et al.
Loss of Prostaglandin D2 Synthase: A key molecular event in the transition of a low grade astrocytoma to an anaplastic astrocytoma
Molecular Cancer Therapeutics 7(10):3420-8, 2008 Oct - Tacon LJ, Parkinson JF, Hudson BJ et al.
Headache of a diagnosis: frontotemporal pain and inflammation associated with osteolysis.
Medical Journal of Australia 189(10):591-2, 2008 Nov 17 - Li D, Brennan JW, Buckland, ME, Parkinson JF
Bronchogenic Carcinoid Metastasis to the Intramedullary Spinal Cord
Journal of Clinical Neuroscience, 17(9):1196-98, 2010 Sept - Parkinson JF, Afaghi V, Payne CA et al.
The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years experience at a single centre
Journal of Clinical Neuroscience, 18(3):329-33, 2011 March - Tan KL, Parkinson JF, McGee-Collett MG, Buckland ME
Spinal intradural malignant peripheral nerve sheath tumour
Pathology, 43(3):278-80, 2011 April - Sevim H, Parkinson JF, McDonald KL
Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?
Journal of Cancer Research and Clinical Oncology 137(11):1705-12, 2011 November - Parker NR, Khong P, Parkinson JF, Howell VM, Wheeler HR.
Molecular heterogeneity in glioblastoma: potential clinical implications.
Frontiers in Oncology 5:55, 2015 Mar 3 - Chan DL, Schembri G, Back M, Bailey DL, Roach PJ, Wheeler H, Cook R, Parkinson J, Lee A, Jayamanne D, Drummond J, Hsiao E.
FET PET in the evaluation of indeterminate brain lesions on MRI: differentiating glioma from other non-neoplastic causes.
European Journal of Nuclear Medicine and Molecular Imaging 42:S603, 2015 Oct (Abstract) - Parker NR, Hudson AL, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Cheng ZJ, Vafaee F, Chen J, Wheeler HR, Howell VM.
Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.
Scientific Reports 6:22477, 2016 Mar 4 - French H, Somasundaram A, Biggs M, Parkinson J, Allan R, Ball J, Little N.
Idiopathic intradural dorsal thoracic arachnoid cysts: A case series and review of the literature.
Journal of Clinical Neuroscience 40:147-152, 2017 Jun - Harris G, Jayamanne D, Wheeler H, Gzell C, Kastelan M, Schembri G, Brazier D, Cook R, Parkinson J, Khasraw M, Louw S, Back M.
Survival outcome of elderly patients with Glioblastoma Multiforme in their seventy fifth year or older treated with adjuvant therapy.
International Journal of Radiation Oncology*Biology*Physics In press, Published online 2017 Feb 20